Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 08/04/2015 5:24:24 AM
Post# of 30066
Avatar
Posted By: redspeed
2015 Jul 24. doi: 10.1002/mds.26326. [Epub ahead of print]
Eltoprazine Prevents Dyskinesias by Reducing Striatal Glutamate and Direct Pathway Neuron Activity.
Paolone G1,2, Brugnoli A1,2, Arcuri L1,2, Mercatelli D1,2, Morari M1,2.
Author information
1Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy.
2Center for Neuroscience and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy.
@ US National Library of Medicine National Institutes of Health
http://www.ncbi.nlm.nih.gov/pubmed/26207892

Eltoprazine Prevents Dyskinesias by Reducing Striatal Glutamate and Direct Pathway Neuron Activity
Giovanna Paolone, Alberto Brugnoli, Ludovico Arcuri, Daniela Mercatelli and Michele Morari
Article first published online: 24 JUL 2015 | DOI: 10.1002/mds.26326

Movement Disorders Early View (Online Version of Record published before inclusion in an issue) © International Parkinson and Movement Disorder Society
http://onlinelibrary.wiley.com/journal/10.100.../earlyview













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site